Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Chamomile Therapy for Generalized Anxiety [Phase 4]
Phase 4 study of chamomile therapy for Generalized Anxiety Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. [Phase 3]
Phase 3 trial assessing efficacy and safety of pregabalin versus placebo for generalized anxiety disorder in subjects discontinuing benzodia…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder [Phase 4]
A Phase 4 trial compared adding Niravam (alprazolam) to an SSRI or SNRI versus SSRI or SNRI alone in generalized anxiety disorder or panic d…
-
FDA approval · 2009-09-30FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic venlafaxine product manufactured by Heritage Pharmaceuticals (d/b/a Avet Pharmaceutica…
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Aripiprazole for the Treatment of Refractory Anxiety [Phase 4]
Phase 4 clinical trial update evaluating aripiprazole for treatment-refractory anxiety, including generalized anxiety disorder and panic dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-08-07FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride).
-
FDA approval · 2009-07-22FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690, authorizing …
-
CLINICAL_TRIALS research · 2009-06-24Clinical Trial Update: Treatment of Youth With ADHD and Anxiety [NA]
A National Institute of Mental Health–sponsored clinical trial evaluating treatments for youth with ADHD and anxiety disorders has completed…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder [Phase 3]
A Phase 3 efficacy and safety study of Seroquel SR for generalized anxiety disorder has completed. Results were posted in 2009.
-
FDA approval · 2009-04-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited, approving changes related to th…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. [Phase 3]
A Phase 3 maintenance trial evaluated the safety and efficacy of quetiapine sustained-release for generalized anxiety disorder and has compl…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating quetiapine fumarate (SEROQUEL) versus placebo in generalized anxiety disorder has completed, assessing safety and e…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder [Phase 3]
This Phase 3 study evaluated the safety and efficacy of quetiapine fumarate (SEROQUEL) versus placebo and an active control in generalized a…
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating efficacy and safety of SR58611A in generalized anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder [Phase 3]
Phase 3 study evaluating SR58611A for Generalized anxiety disorder has completed an eight-week efficacy and safety evaluation.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder [Phase 3]
A Phase 3 study evaluating SR58611A for generalized anxiety disorder in elderly patients has been terminated in an eight-week trial.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder [Phase 3]
A Phase 3 relapse-prevention study of SR58611A in patients with Generalized Anxiety Disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder [Phase 3]
This update reports the results of a Phase 3 eight-week trial evaluating the efficacy and safety of SR58611A in adults with generalized anxi…
-
FDA approval · 2009-03-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited. This approval authorizes a gene…
-
FDA approval · 2009-02-27FDA Approved: BUSPIRONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for buspirone hydrochloride from Aurobindo Pharma Limited, creating a generic version of buspirone.
-
FDA approval · 2009-01-30FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE from Apotex Corp.
-
FDA approval · 2009-01-30FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride), authorizing a generic version under the exist…
-
FDA approval · 2009-01-27FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, enabling marketing of a generic venlafaxine hydrochloride produc…
-
FDA approval · 2009-01-09FDA Approved: VENLAFAXINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic venlafaxine product under Heritage Pharmaceuticals’ original ANDA, for the treatment of major depressive disorder and…
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study [NA]
A terminated clinical trial examined the effects of duloxetine on pathological worry in generalized anxiety disorder using functional MRI.